BIND Therapeutics (BIND) Posts Quarterly Results
BIND Therapeutics (NASDAQ:BIND) released its earnings data on Friday. The company reported ($0.51) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.49) by $0.02, Stock Ratings Network.com reports.
BIND Therapeutics (NASDAQ:BIND) traded up 2.92% on Friday, hitting $9.17. The stock had a trading volume of 5,236 shares. BIND Therapeutics has a one year low of $8.36 and a one year high of $15.89. The stock’s 50-day moving average is $10.47 and its 200-day moving average is $12.11. The company’s market cap is $150.5 million.
BIND Therapeutics Inc is a clinical-stage nanomedicine platform company developing Accurins, its targeted and programmable therapeutics.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.